CVE-2026-13588A vulnerability was determined in seladb PcapPlusPlus 25.05.
Updated under an hour ago ()
Does this affect you?
It lists no affected products yet. Add what you run and Signals checks it as products are added.
No exploitation reported and no EPSS estimate yet.
A vulnerability was determined in seladb PcapPlusPlus 25.05. The impacted element is the function pcpp::SSLClientHelloMessage::getHandshakeVersion of the file Packet++/src/SSLHandshake.cpp of the component TLS Hello Handler. Executing a manipulation of the argument handshakeVersion can lead to heap-based buffer overflow. It is possible to launch the attack remotely. This attack is characterized by high complexity. The exploitability is regarded as difficult. The exploit has been publicly disclosed and may be utilized. This patch is called 98e671010bc7c87b95898c22ae289220ae92542b. It is best practice to apply a patch to resolve this issue.
- CVSS
- 5.6 MEDIUM (v3.1, NVD)CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:L/I:L/A:L
- Weakness (CWE)
- CWE-119, CWE-122
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Not given
- NVD analysis
- Deferred
- Record last updated
- Jun 29, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
No affected products are listed yet.
References
- https://github.com/seladb/PcapPlusPlus/
- https://github.com/seladb/PcapPlusPlus/commit/98e671010bc7c87b95898c22ae289220ae92542b
- https://github.com/seladb/PcapPlusPlus/issues/2151
- https://github.com/seladb/PcapPlusPlus/pull/2161
- https://github.com/user-attachments/files/28213479/poc.zip
- https://vuldb.com/cve/CVE-2026-13588
- https://vuldb.com/submit/844481
- https://vuldb.com/vuln/374591
- https://vuldb.com/vuln/374591/cti
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.